Free tool
FAERS Monitor: Viread
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022577 or its brand name (Viread, Tenofovir Disoproxil Fumarate). Reports on generic versions are filed under their own applications.
Reports
32,964
Serious
30,987
94% of reports
Hospitalization
6,403
Death reported
1,955
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- bone density decreased10,696
- renal injury9,285
- skeletal injury8,338
- chronic kidney disease7,310
- osteonecrosis7,271
- bone loss7,084
- multiple fractures6,842
- renal failure6,700
- osteoporosis5,420
- tooth loss4,538
- pain3,040
- emotional distress2,861
- anxiety2,677
- anhedonia2,459
- osteopenia2,270
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 578 |
| 2005 | 639 |
| 2006 | 526 |
| 2007 | 566 |
| 2008 | 530 |
| 2009 | 573 |
| 2010 | 473 |
| 2011 | 556 |
| 2012 | 495 |
| 2013 | 530 |
| 2014 | 932 |
| 2015 | 1,213 |
| 2016 | 1,209 |
| 2017 | 1,322 |
| 2018 | 1,506 |
| 2019 | 1,938 |
| 2020 | 12,186 |
| 2021 | 2,741 |
| 2022 | 1,734 |
| 2023 | 1,093 |
| 2024 | 751 |
| 2025 | 589 |
| 2026 | 279 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,195 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| skeletal injurySignal | 8,338 | 2640.1 | 2517.8 | 4,281,041 |
| bone lossSignal | 7,084 | 567.2 | 550.4 | 2,120,373 |
| multiple fracturesSignal | 6,842 | 454.4 | 441.4 | 1,808,582 |
| bone density decreasedSignal | 10,696 | 330.0 | 323.2 | 2,315,185 |
| renal injurySignal | 9,285 | 289.4 | 283.1 | 1,838,112 |
| osteonecrosisSignal | 7,271 | 181.1 | 176.8 | 1,015,536 |
| tooth lossSignal | 4,538 | 178.4 | 173.0 | 626,144 |
| osteopeniaSignal | 2,270 | 112.0 | 107.3 | 212,542 |
| osteoporosisSignal | 5,420 | 96.7 | 94.2 | 446,428 |
| chronic kidney diseaseSignal | 7,310 | 67.8 | 66.4 | 436,429 |
| anhedoniaSignal | 2,459 | 65.8 | 63.2 | 142,271 |
| renal failureSignal | 6,700 | 33.8 | 33.1 | 204,070 |
| emotional distressSignal | 2,861 | 15.4 | 14.9 | 37,870 |
| anxietySignal | 2,677 | 6.0 | 5.8 | 11,325 |
| painSignal | 3,040 | 3.2 | 3.1 | 4,622 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.